Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
101
datasets available to search
ShareScore release 0.9.0
Dataset results
101 results for “WITHDRAWAL TREATMENT”
Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
ClinicalTrials.gov study NCT00865020. IPD Sharing: Not stated. Countries: 16. Publications: 3.
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03410992. IPD Sharing: NO. Countries: 9. Publications: 7.
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
ClinicalTrials.gov study NCT02207244. IPD Sharing: Not stated. Countries: 9. Publications: 10.
Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone
ClinicalTrials.gov study NCT04762537. IPD Sharing: YES. Countries: 1. Publications: 3.
A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01186744. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
ClinicalTrials.gov study NCT04470050. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
ClinicalTrials.gov study NCT06711887. IPD Sharing: YES. Countries: 8. Publications: 1.
Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)
ClinicalTrials.gov study NCT03253796. IPD Sharing: YES. Countries: 9. Publications: 1.
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
ClinicalTrials.gov study NCT01430754. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
ClinicalTrials.gov study NCT02621892. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal
ClinicalTrials.gov study NCT00480441. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
ClinicalTrials.gov study NCT01863186. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD
ClinicalTrials.gov study NCT04759703. IPD Sharing: YES. Countries: 1. Publications: 3.
Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
ClinicalTrials.gov study NCT04214834. IPD Sharing: YES. Countries: 1. Publications: 1.
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy:
ClinicalTrials.gov study NCT05151861. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)
ClinicalTrials.gov study NCT04455802. IPD Sharing: NO. Countries: 1. Publications: 10.
Magnesium After Alcohol Withdrawal Treatment
ClinicalTrials.gov study NCT00325299. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction
ClinicalTrials.gov study NCT05880160. IPD Sharing: NO. Countries: 1. Publications: 1.
A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal
ClinicalTrials.gov study NCT00523185. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome
ClinicalTrials.gov study NCT00146471. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.